Author

P. Waranecki

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1 Assay:proteomics· 1

Frequent Co-Authors

D. S. Metselaar· 1 shared E. Hulleman· 1 shared G. J. Kaspers· 1 shared J. Koster· 1 shared J. R. Goulding· 1 shared M. Breur· 1 shared M. Bugiani· 1 shared M. C. de Gooijer· 1 shared

Activity by Year

2023-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

D. S. Metselaar

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Gemcitabine therapeutically disrupts essential SIRT1-mediated p53 repression in Atypical Teratoid/Rhabdoid Tumors

D. S. Metselaar, M. H. Meel, J. R. Goulding, P. Waranecki, M. C. de Gooijer, M. Breur, J. Koster, S. E. Veldhuijzen van Zanten, M. Bugiani, P. Wesseling, G. J. Kaspers, E. Hulleman

This study shows gemcitabine selectively kills ATRT by degrading SIRT1, activating p53 and SHH signaling, and significantly improves survival in xenograft models.

bioRxiv · Sep 2, 2023Cancer Biology